Avience Biomedicals Ltd vs Ccme Global Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Avience Biomedicals Ltd is ₹ 240 as of 23 Oct 15:30 . The P/E Ratio of Avience Biomedicals Ltd is 0 as of March 2024 .The P/E Ratio of CCME Global Ltd is 0 as of March 2024 . The Market Cap of Avience Biomedicals Ltd is ₹ 0 crore as of March 2024 .The Market Cap of CCME Global Ltd is ₹ 0 crore as of March 2024 . The revenue of Avience Biomedicals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of CCME Global Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0.04 crore. This represent the decline of -100% The ebitda of Avience Biomedicals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of CCME Global Ltd for the Jun '26 is ₹ -0.24 crore as compare to the Mar '26 ebitda of ₹ -0.5 crore. This represent the decline of -52% The net profit of Avience Biomedicals Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of CCME Global Ltd changed from ₹ -0.1 crore to ₹ -0.26 crore over 9 quarters. This represents a CAGR of 52.91% The Dividend Payout of Avience Biomedicals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of CCME Global Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Avience Biomedicals Ltd

Avience Biomedicals Limited was originally incorporated as Private Limited Company as 'Avience Biomedicals Private Limited' on December 23, 2019 with the Registrar of Companies, Delhi.
Later, Company's status got converted into a Public Limited Company, the name of the Company was changed to 'Avience Biomedicals Limited' and fresh Certificate of incorporation dated September 3, 2024, was issued by the Registrar of Companies, Delhi. Avience Biomedicals Limited is a medical consumable company dedicated to manufacturing of Vitro-Diagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India.
In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections. The Company commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM), Covid, Human Immunodeficiency Viruses (HIV), HBs AG, Malaria, Dengue and others aimed at aiding medical institutions with affordable and good-quality solutions.

About CCME Global Ltd

Genesis IBRC India Limited was formerly incorporated as Fine Plast Polymers Limited in October, 1992.
Thereafter, the name of the Company was changed from Fine Plast Polymers Limited to SSK Lifestyles Limited in October, 2014 and further was changed from SSK Lifestyles Limited to Genesis IBRC India Limited in January, 2018.
Promoted by P M Rao, P Janardhana Rao, P Rama Rao and their Associates, the Company came out with a public issue in Dec.'93 to part-finance the setting up of its plant in Pamur, Andhra Pradesh.
The plant has an installed capacity of 432 tpa for rigid PVC pipes and 778 tpa for PVC fittings. Initially, Company manufactured rigid PVC pipes and fittings like tees, elbows, adopters, reducers, end caps, etc. used in agriculture and agro-based activities like sprinkler irrigation systems, process piping, oil and gas and shipping industries.

FAQs for the comparison of Avience Biomedicals Ltd and CCME Global Ltd

Which company has a larger market capitalization, Avience Biomedicals Ltd or CCME Global Ltd?

Market cap of Avience Biomedicals Ltd is 131 Cr while Market cap of CCME Global Ltd is 136 Cr

What are the key factors driving the stock performance of Avience Biomedicals Ltd and CCME Global Ltd?

The stock performance of Avience Biomedicals Ltd and CCME Global Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Avience Biomedicals Ltd and CCME Global Ltd?

As of October 25, 2026, the Avience Biomedicals Ltd stock price is INR ₹240.0. On the other hand, CCME Global Ltd stock price is INR ₹30.22.

How do dividend payouts of Avience Biomedicals Ltd and CCME Global Ltd compare?

To compare the dividend payouts of Avience Biomedicals Ltd and CCME Global Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.